These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20955822)

  • 1. Solid cancer, antiphospholipid antibodies, and venous thromboembolism.
    Font C; Vidal L; Espinosa G; Tàssies D; Monteagudo J; Farrús B; Visa L; Cervera R; Gascon P; Reverter JC
    Autoimmun Rev; 2011 Feb; 10(4):222-7. PubMed ID: 20955822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross sectional study of antiphospholipid-protein antibodies in patients with venous thromboembolism.
    Pasquier E; Amiral J; de Saint Martin L; Mottier D
    Thromb Haemost; 2001 Aug; 86(2):538-42. PubMed ID: 11522000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study.
    Vormittag R; Simanek R; Ay C; Dunkler D; Quehenberger P; Marosi C; Zielinski C; Pabinger I
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2176-81. PubMed ID: 19778945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of antiphospholipid antibodies in Syrian patients with thrombosis.
    Deeb A; Hamdoun S; Dababo K
    Iran J Immunol; 2009 Sep; 6(3):154-9. PubMed ID: 19801789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).
    Imberti D; Di Nisio M; Donati MB; Falanga A; Ghirarduzzi A; Guarneri D; Piovella F; Santoro RC; Baldini E; Zampogna S;
    Thromb Res; 2009 Nov; 124(5):e32-40. PubMed ID: 19744700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.
    Khorana AA; Francis CW; Culakova E; Kuderer NM; Lyman GH
    Cancer; 2007 Nov; 110(10):2339-46. PubMed ID: 17918266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients.
    Kansuttiviwat C; Niprapan P; Tantiworawit A; Norasetthada L; Rattarittamrong E; Rattanathammethee T; Hantrakool S; Piriyakhuntorn P; Punnachet T; Hantrakun N; Chai-Adisaksopha C
    PLoS One; 2023; 18(1):e0279450. PubMed ID: 36662720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factor.
    Delluc A; Rousseau A; Delluc C; Le Moigne E; Le Gal G; Mottier D; Van Dreden P; Lacut K
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):295-300. PubMed ID: 21372691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibodies and malignancies.
    Tincani A; Taraborelli M; Cattaneo R
    Autoimmun Rev; 2010 Feb; 9(4):200-2. PubMed ID: 19386286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory evaluation of antiphospholipid antibodies in patients with venous thromboembolism.
    Hirmerova J; Ulcova-Gallova Z; Seidlerova J; Filipovsky J; Bibkova K; Micanova Z; Mayer O
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):318-25. PubMed ID: 19221100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between ABO blood types and venous thromboembolism in individuals with a positive antiphospholipid profile is varied by sex.
    Shusterman M; Golub E; Mowrey WB; Broder A
    Lupus; 2018 Feb; 27(2):319-326. PubMed ID: 28705035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
    Vemulapalli S; Chintala L; Tsimberidou AM; Dhillon N; Lei X; Hong D; Kurzrock R
    Am J Hematol; 2009 Jul; 84(7):408-13. PubMed ID: 19437507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism.
    Zanon E; Saggiorato G; Ramon R; Girolami A; Pagnan A; Prandoni P
    Thromb Haemost; 2004 Feb; 91(2):255-8. PubMed ID: 14961151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies and antiphospholipid syndrome in patients with malignancies: features, incidence, identification, and treatment.
    Miesbach W
    Semin Thromb Hemost; 2008 Apr; 34(3):282-5. PubMed ID: 18720308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of high titre of antiphospholipid antibodies on postoperative outcome following pulmonary endarterectomy.
    D'Armini AM; Totaro P; Nicolardi S; Morsolini M; Silvaggio G; Toscano F; Toscano M; Viganò M
    Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):418-22. PubMed ID: 19934162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Di Micco P; Iannuzzo M; Lecumberri R; Guijarro R; Madridano O; Monreal M;
    Thromb Haemost; 2008 Nov; 100(5):905-11. PubMed ID: 18989537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
    Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.